BI 764532
Boehringer Ingelheim
['rebirth', 'sclc', 'lcsm,(-blcsm)']
bi 764532, dll3/cd3 t cell engaging bispecific ab targeting cd3 + dll3 in pre-treated sclc. may it be the rebirth of dll3 as a potential target in sclc? promising signals of efficacy (orr 25%) with durable responses. #asco23 #lcsm 
Husband, Father.
Medical Oncologist and Researcher focused in Thoracic Oncology.
Views are my own.